Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.
Carlo-Stella C, Ricci F, Dalto S, Mazza R, Malagola M, Patriarca F, Viviani S, Russo D, Giordano L, Castagna L, Corradini P, Santoro A. Carlo-Stella C, et al. Among authors: dalto s. Oncologist. 2015 Mar;20(3):323-8. doi: 10.1634/theoncologist.2014-0420. Epub 2015 Feb 10. Oncologist. 2015. PMID: 25669663 Free PMC article.
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Farina L, Rezzonico F, Spina F, Dodero A, Mazzocchi A, Crippa F, Alessi A, Dalto S, Viviani S, Corradini P. Farina L, et al. Among authors: dalto s. Biol Blood Marrow Transplant. 2014 Dec;20(12):1982-8. doi: 10.1016/j.bbmt.2014.08.016. Epub 2014 Aug 23. Biol Blood Marrow Transplant. 2014. PMID: 25240818 Free article.
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
Dodero A, Spina F, Narni F, Patriarca F, Cavattoni I, Benedetti F, Ciceri F, Baronciani D, Scimè R, Pogliani E, Rambaldi A, Bonifazi F, Dalto S, Bruno B, Corradini P. Dodero A, et al. Among authors: dalto s. Leukemia. 2012 Mar;26(3):520-6. doi: 10.1038/leu.2011.240. Epub 2011 Sep 9. Leukemia. 2012. PMID: 21904377 Free article.
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Montefusco V, Galli M, Spina F, Stefanoni P, Mussetti A, Perrone G, De Philippis C, Dalto S, Maura F, Bonini C, Rezzonico F, Pennisi M, Roncari L, Soldarini M, Dodero A, Farina L, Cocito F, Caprioli C, Corradini P. Montefusco V, et al. Among authors: dalto s. Leuk Lymphoma. 2014 Sep;55(9):2032-7. doi: 10.3109/10428194.2014.914203. Epub 2014 Jun 5. Leuk Lymphoma. 2014. PMID: 24730540
Increased incidence of interstitial pneumonia detected on [18F]-FDG-PET/CT in asymptomatic cancer patients during COVID-19 pandemic in Lombardy: a casualty or COVID-19 infection?
Setti L, Bonacina M, Meroni R, Kirienko M, Galli F, Dalto SC, Erba PA, Bombardieri E. Setti L, et al. Among authors: dalto sc. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):777-785. doi: 10.1007/s00259-020-05027-y. Epub 2020 Sep 9. Eur J Nucl Med Mol Imaging. 2021. PMID: 32909090 Free PMC article.
Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation.
Greco R, Lorentino F, Morelli M, Giglio F, Mannina D, Assanelli A, Mastaglio S, Dalto S, Perini T, Lazzari L, Piemontese S, Corti C, Marcatti M, Bernardi M, Lupo Stanghellini MT, Ciceri F, Peccatori J. Greco R, et al. Among authors: dalto s. Blood. 2016 Sep 15;128(11):1528-31. doi: 10.1182/blood-2016-06-723205. Epub 2016 Aug 5. Blood. 2016. PMID: 27495140 Free article. No abstract available.
Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome.
Angeli E, Dalto S, Marchese S, Setti L, Bonacina M, Galli F, Rulli E, Torri V, Monti C, Meroni R, Beretta GD, Castoldi M, Bombardieri E. Angeli E, et al. Among authors: dalto s. Eur J Radiol. 2021 Apr;137:109612. doi: 10.1016/j.ejrad.2021.109612. Epub 2021 Feb 26. Eur J Radiol. 2021. PMID: 33662842 Free PMC article.
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
Lazzeri M, Duga S, Azzolini E, Fasulo V, Buffi N, Saita A, Lughezzani G, Paraboschi EM, Hurle R, Nobili A, Cecconi M, Guazzoni G, Casale P, Asselta R; Humanitas COVID-19 Task Force, The Humanitas Gavazzeni COVID-19 Task Force. Lazzeri M, et al. Minerva Urol Nephrol. 2022 Feb;74(1):77-84. doi: 10.23736/S2724-6051.20.04081-3. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439572 Free article.